4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-25-000008
CFO AND TREASURER sold 21,000 shares at an average $479.99 ($10,079,696)
- CFO AND TREASURER acquired 21,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +21,000 | $146.03 | $3,066,630 | 29,142 | D |
| 2025-12-01 | Sale : show line 2 in the form 10b5-1 | −2,853 | $477.98 | $1,363,672 | 26,289 | D |
| 2025-12-01 | Sale : show line 3 in the form 10b5-1 | −4,198 | $479.11 | $2,011,284 | 22,091 | D |
| 2025-12-01 | Sale : show line 4 in the form 10b5-1 | −7,552 | $479.92 | $3,624,368 | 14,539 | D |
| 2025-12-01 | Sale : show line 5 in the form 10b5-1 | −3,858 | $480.95 | $1,855,492 | 10,681 | D |
| 2025-12-01 | Sale : show line 6 in the form 10b5-1 | −1,476 | $481.80 | $711,143 | 9,205 | D |
| 2025-12-01 | Sale : show line 7 in the form 10b5-1 | −903 | $483.04 | $436,188 | 8,302 | D |
| 2025-12-01 | Sale : show line 8 in the form 10b5-1 | −160 | $484.68 | $77,549 | 8,142 | D |
| Open-market sales · 21,000 sh · avg $479.99 · $10,079,696 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2025-12-01 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option | −517 | $146.03 | 2027-03-15 | 517 | 0 | D |
| 2025-12-01 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −20,483 | $146.03 | 2027-03-15 | 20,483 | 24,517 | D |
Loading xslF345X05/primarydocument.xml…